Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits

Clinical Science

Volumn 100, Issue 3, 2001, Pages 291-298

  Kim, B O ^a   Shin, S S ^a   Yoo, Y H ^a   Pyo, S ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

CTXA2B; Helicobacter pylori adhesin; Vaccination

Indexed keywords

ADHESIN; CHOLERA TOXIN; CHOLERA TOXIN A2B; GANGLIOSIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; GEL PERMEATION CHROMATOGRAPHY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; WESTERN BLOTTING;

ADHESINS, BACTERIAL; ANIMALS; CHOLERA TOXIN; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

EID: 0035109036     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000142     Document Type: Article

References (41)

1. Parasitism by the slow bacterium Helicobacter pylori leads to alter gastric homestasis and neoplasia
2. Role of Helicobacter pylori virulence factors vacuolating cytotoxin, CagA and urease in a mouse model of disease
3. Development of a mouse model of Helicobacter pylori infection that mimics human disease
4. The epidemiology of Helicobacter pylori infection
5. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
6. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection
7. Enzyme-linked immunosorbent assay for detection of immunoglobulin A and G antibodies to Campylobacter pylori
8. Evidence of weakening of gastric mucus integrity by Campylobacter pylori
9. Cloning, nucleotide sequence and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori
10. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGS cells
11. Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori
12. Helicobacterpylori: Receptors and adhesins
13. The common mucosal immune system and current strategies for induction of immune response in external secretions
14. Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer; potential for new therapies and vaccines
15. New cholera toxin vaccine
16. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response
17. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues
18. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit
19. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits
20. Disribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit
21. Expression and characterization of Helicobacter pylori adhesin protein linked to cholera toxin A2/B subunits in Escherichia coli
22. Large-scale production of recombinant human epidermal growth factor and its development as a new drug
23. Recombinant cholera toxin B subunit in Escherichia coli: High-level secretion, purification, and characterization
24. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development
25. Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme
26. The purification of eukaryotic polypeptides synthesized in Escherichia coli
27. A lavage technique allowing repeated measurement of IgA in mouse intestinal secretions
28. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
29. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
30. Modified Steiner method for the demonstration of spirochetes
31. Systemic immunization with urease protects mice against Helicobacter pylori infection
32. Evaluation of virulence in animal models
33. Original isolation of Campylobacter pyloridis from human gastric mucosa
34. Molecular characterization of a conserved 20-kilodalton membrane-associated lipoprotein antigen of Helicobacter pylori
35. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions
36. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies
37. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
38. Atrophic gastric changes in both H. fells and H. pylori infected mice are host dependent and separate from antral gastritis
39. A small animal model of human Helicobacter pylori active chronic gastritis
40. Further development of the Helicobacter pylori mouse vaccination model